Axsome Therapeutics Statistics
Total Valuation
AXSM has a market cap or net worth of $3.75 billion. The enterprise value is $3.61 billion.
| Market Cap | 3.75B |
| Enterprise Value | 3.61B |
Important Dates
The next estimated earnings date is Monday, August 5, 2024, before market open.
| Earnings Date | Aug 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AXSM has 47.50 million shares outstanding. The number of shares has increased by 8.89% in one year.
| Shares Outstanding | 47.50M |
| Shares Change (YoY) | +8.89% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 17.04% |
| Owned by Institutions (%) | 82.64% |
| Float | 35.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.93 |
| Forward PS | 8.73 |
| PB Ratio | 26.03 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 14.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.20, with a Debt / Equity ratio of 1.31.
| Current Ratio | 3.20 |
| Quick Ratio | 3.01 |
| Debt / Equity | 1.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -55.54 |
Financial Efficiency
Return on equity (ROE) is -134.20% and return on invested capital (ROIC) is -87.95%.
| Return on Equity (ROE) | -134.20% |
| Return on Assets (ROA) | -50.50% |
| Return on Capital (ROIC) | -87.95% |
| Revenue Per Employee | $460,593 |
| Profits Per Employee | -$543,811 |
| Employee Count | 545 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 2.11 |
Taxes
| Income Tax | -1.62M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.37% in the last 52 weeks. The beta is 1.25, so AXSM's price volatility has been higher than the market average.
| Beta (5Y) | 1.25 |
| 52-Week Price Change | +12.37% |
| 50-Day Moving Average | 75.16 |
| 200-Day Moving Average | 74.80 |
| Relative Strength Index (RSI) | 57.20 |
| Average Volume (20 Days) | 907,239 |
Short Selling Information
The latest short interest is 8.89 million, so 18.72% of the outstanding shares have been sold short.
| Short Interest | 8.89M |
| Short Previous Month | 8.27M |
| Short % of Shares Out | 18.72% |
| Short % of Float | 25.11% |
| Short Ratio (days to cover) | 12.87 |
Income Statement
In the last 12 months, AXSM had revenue of $251.02 million and -$296.38 million in losses. Loss per share was -$6.43.
| Revenue | 251.02M |
| Gross Profit | 226.22M |
| Operating Income | -292.73M |
| Pretax Income | -298.00M |
| Net Income | -296.38M |
| EBITDA | -284.23M |
| EBIT | -292.73M |
| Loss Per Share | -$6.43 |
Balance Sheet
The company has $331.44 million in cash and $188.80 million in debt, giving a net cash position of $142.64 million or $3.00 per share.
| Cash & Cash Equivalents | 331.44M |
| Total Debt | 188.80M |
| Net Cash | 142.64M |
| Net Cash Per Share | $3.00 |
| Equity (Book Value) | 144.04M |
| Book Value Per Share | 3.03 |
| Working Capital | 316.44M |
Cash Flow
In the last 12 months, operating cash flow was -$192.73 million and capital expenditures -$609,000, giving a free cash flow of -$193.34 million.
| Operating Cash Flow | -192.73M |
| Capital Expenditures | -609,000 |
| Free Cash Flow | -193.34M |
| FCF Per Share | -$4.08 |
Margins
Gross margin is 90.12%, with operating and profit margins of -116.61% and -118.07%.
| Gross Margin | 90.12% |
| Operating Margin | -116.61% |
| Pretax Margin | -118.71% |
| Profit Margin | -118.07% |
| EBITDA Margin | -113.23% |
| EBIT Margin | -116.61% |
| FCF Margin | -77.02% |
Dividends & Yields
AXSM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.89% |
| Shareholder Yield | -8.89% |
| Earnings Yield | -7.91% |
| FCF Yield | -5.16% |
Analyst Forecast
The average price target for AXSM is $123.55, which is 56.53% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $123.55 |
| Price Target Difference | 56.53% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 50.09% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AXSM has an Altman Z-Score of 2.67 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.67 |
| Piotroski F-Score | 2 |